ROCO
4198
Market cap35mUSD
Oct 08, Last price
47.15TWD
1D
0.32%
1Q
3.85%
Jan 2017
-89.93%
IPO
-95.19%
Name
S&S Healthcare Holding Ltd
Chart & performance
P/E
—
P/S
5.57
EPS
—
Div yield, %
—
Shrs. gr., 5y
14.40%
Rev. gr., 5y
15.04%
Revenues
204m
-15.00%
Net income
-47m
L+14.57%
CFO
-27m
L-48.77%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
S&S Healthcare Holding Ltd. is dedicated to the research, manufacturing, and global commercialization of medical imaging equipment. The company's operations extend across international markets, including significant presences in Taiwan, the United States, and Switzerland. Its product portfolio encompasses advanced digital diagnostic X-ray systems, alongside the engineering and production of devices for bone densitometry and body composition assessment. Established in 1988, S&S Healthcare maintains its headquarters in Taipei, Taiwan. The firm adopted its current name in August 2020, having previously operated as Swissray Global Healthcare Holding Ltd.
Key people
Chairman of the Board · since 2023
Guodong Lin
Chief Operating Officer, General Manager, Director · since 2025
Rouzhen Chen
Corporate Governance Officer · since 2024
Yuxiang Huang
Head of Finance & Accounting · since 2022
Yongzhi Ding
Director · since 2022
Vice Chairman of the Board, Director · since 2025
Yun Liang
Director · since 2013
Muqi Huang
Independent Director · since 2020
Jiazheng Zhang
Independent Director · since 2022
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||